Who
Thermopylae Holdings Ltd.
10% owner
Company insider
Files Form 4 as: 10% owner, AbCellera Biologics.
In numbers
- Trades disclosed
- 22
- Buys
- 13
- Sells
- 1
- Bought
- $22.3M
- Sold
- $134.5M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 24 May 2021
- Last trade
- 27 Feb 2026
- Last filed
- 2 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Feb 2026filed 2 Mar 2026 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $131K38,000 at $3.44 | filing |
| 27 Feb 2026filed 2 Mar 2026 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $131K38,000 at $3.44 | filing |
| 26 Feb 2026filed 27 Feb 2026 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $580K177,457 at $3.27 | filing |
| 26 Feb 2026filed 27 Feb 2026 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $580K177,457 at $3.27 | filing |
| 18 Dec 2025filed 19 Dec 2025 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Code G | —225,000 at $0.00 | filing |
| 11 Mar 2025filed 11 Mar 2025 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $742K343,631 at $2.16 | filing |
| 4 Dec 2024filed 5 Dec 2024 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Code G | —286,000 at $0.00 | filing |
| 29 Aug 2024filed 29 Aug 2024 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $740K283,516 at $2.61 | filing |
| 19 Dec 2023filed 19 Dec 2023 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Code G | —210,000 at $0.00 | filing |
| 26 May 2023filed 26 May 2023 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $998K153,000 at $6.52 | filing |
| 16 Dec 2022filed 20 Dec 2022 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $860K85,102 at $10.10 | filing |
| 31 Oct 2022filed 9 Nov 2022 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Code G | —70,000 at $0.00 | filing |
| 19 Aug 2022filed 22 Aug 2022 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $2.3M200,000 at $11.46 | filing |
| 14 Jun 2022filed 15 Jun 2022 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $74K9,173 at $8.05 | filing |
| 13 Jun 2022filed 15 Jun 2022 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $441K54,915 at $8.03 | filing |
| 6 Jun 2022filed 8 Jun 2022 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $484K64,545 at $7.50 | filing |
| 13 May 2022filed 17 May 2022 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $2.2M300,000 at $7.26 | filing |
| 12 May 2022filed 16 May 2022 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $9.0M1,408,468 at $6.41 | filing |
| 7 Dec 2021filed 3 Feb 2022 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Code G | —750,000 at $0.00 | filing |
| 11 Nov 2021filed 15 Nov 2021 | ABCL AbCellera BiologicsBiotechnology | SEC FORM 4 Bought | $3.0M202,960 at $14.76 | filing |
News
AbCellera Biologics (NASDAQ:ABCL) Research Coverage Started at UBS GroupABCL · themarketsdaily.com · 15 Oct 2026Head to Head Review: Surrozen (NASDAQ:SRZN) vs. AbCellera Biologics (NASDAQ:ABCL)ABCL · tickerreport.com · 14 Oct 2026Contrasting Sarepta Therapeutics (NASDAQ:SRPT) & AbCellera Biologics (NASDAQ:ABCL)ABCL · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Thermopylae Holdings Ltd.; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.